Works by Gurion, Ronit

Results: 57
    1
    2
    3
    4
    5
    6

    Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 1, p. 118, doi. 10.1080/10428194.2020.1824069
    By:
    • Segman, Yafit;
    • Ribakovsky, Elena;
    • Avigdor, Abraham;
    • Goldhecht, Yair;
    • Vainstein, Vladimir;
    • Goldschmidt, Neta;
    • Harlev, Shimrit;
    • Horwitz, Netanel;
    • Gutwein, Odit;
    • Gurion, Ronit;
    • Itchaki, Gilad;
    • Abadi, Uri;
    • Nemets, Anatoly;
    • Sofer, Orit;
    • Zektser, Miri;
    • Tadmor, Tamar;
    • Dally, Nagib;
    • Filanovsky, Kalman;
    • Leiba, Merav;
    • Sarid, Nadav
    Publication type:
    Article
    7
    8
    9

    Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 5, p. 1163, doi. 10.1080/10428194.2017.1375102
    By:
    • Bentur, Ohad S.;
    • Sarid, Nadav;
    • Ram, Ron;
    • Herishanu, Yair;
    • Avivi, Irit;
    • Perry, Chava;
    • Kreiniz, Natalia;
    • Dally, Najib;
    • Gurion, Ronit;
    • Raanani, Pia;
    • Gafter-Gvili, Anat;
    • Gutwein, Odit;
    • Gatt, Moshe;
    • Paltiel, Ora;
    • Shvidel, Lev;
    • Ganzel, Chezi;
    • Horowitz, Netanel A.
    Publication type:
    Article
    10
    11
    12
    13

    A phase 2 study of ibrutinib maintenance following first‐line high‐dose methotrexate‐based chemotherapy for elderly patients with primary central nervous system lymphoma.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 24, p. 3905, doi. 10.1002/cncr.34985
    By:
    • Bairey, Osnat;
    • Taliansky, Alisa;
    • Glik, Amir;
    • Amiel, Alexandra;
    • Yust‐Katz, Shlomit;
    • Gurion, Ronit;
    • Zektser, Miri;
    • Porges, Tzvika;
    • Sarid, Nadav;
    • Horowitz, Netanel A.;
    • Shina, Tzahala Tzuk;
    • Lebel, Eyal;
    • Cohen, Amos;
    • Geiger, Karyn Revital;
    • Raanani, Pia;
    • Wolach, Ofir;
    • Siegal, Tali
    Publication type:
    Article
    14
    15
    16
    17
    18

    Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 1, p. 97, doi. 10.1002/hon.3096
    By:
    • Vassilakopoulos, Theodoros P.;
    • Panitsas, Fotios;
    • Mellios, Zois;
    • Apostolidis, John;
    • Michael, Michalis;
    • Gurion, Ronit;
    • Ferhanoglu, Burhan;
    • Hatzimichael, Eleftheria;
    • Karakatsanis, Stamatios;
    • Dimou, Maria;
    • Kalpadakis, Christina;
    • Katodritou, Eirini;
    • Leonidopoulou, Theoni;
    • Kotsianidis, Ioannis;
    • Giatra, Hara;
    • Kanellias, Nick;
    • Sayyed, Ayman;
    • Tadmor, Tamar;
    • Akay, Olga Meltem;
    • Angelopoulou, Maria K.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.

    Published in:
    2021
    By:
    • Maerevoet, Marie;
    • Zijlstra, Josee M.;
    • Follows, George;
    • Casasnovas, Rene-Olivier;
    • Vermaat, J. S. P.;
    • Kalakonda, Nagesh;
    • Goy, Andre;
    • Choquet, Sylvain;
    • Van Den Neste, Eric;
    • Hill, Brian;
    • Thieblemont, Catherine;
    • Cavallo, Federica;
    • De la Cruz, Fatima;
    • Kuruvilla, John;
    • Hamad, Nada;
    • Jaeger, Ulrich;
    • Caimi, Paolo;
    • Gurion, Ronit;
    • Warzocha, Krzysztof;
    • Bakhshi, Sameer
    Publication type:
    Letter
    32
    33
    34
    35
    36
    37
    38
    39

    Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. 483, doi. 10.1016/j.clml.2021.12.016
    By:
    • Schuster, Michael;
    • Zijlstra, Josée;
    • Casasnovas, Rene-Olivier;
    • Vermaat, Joost S. P.;
    • Kalakonda, Nagesh;
    • Goy, Andre;
    • Choquet, Sylvain;
    • Neste, Eric Van Den;
    • Hill, Brian;
    • Thieblemont, Catherine;
    • Cavallo, Federica;
    • Cruz, Fatima De la;
    • Kuruvilla, John;
    • Hamad, Nad;
    • Jaeger, Ulrich;
    • Caimi, Paolo;
    • Gurion, Ronit;
    • Warzocha, Krzysztof;
    • Bakhshi, Sameer;
    • Sancho, Juan-Manuel
    Publication type:
    Article
    40

    Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 24, doi. 10.1016/j.clml.2021.07.017
    By:
    • Casasnovas, Rene-Olivier;
    • Follows, George;
    • Zijlstra, Josee M.;
    • Vermaat, Joost S.P.;
    • Kalakonda, Nagesh;
    • Choquet, Sylvain;
    • Van Den Neste, Eric;
    • Hill, Brian;
    • Thieblemont, Catherine;
    • Cavallo, Federica;
    • De la Cruz, Fatima;
    • Kuruvilla, John;
    • Hamad, Nada;
    • Jaeger, Ulrich;
    • Caimi, Paolo F.;
    • Gurion, Ronit;
    • Warzocha, Krzysztof;
    • Bakhshi, Sameer;
    • Sancho, Juan-Manuel;
    • Schuster, Michael
    Publication type:
    Article
    41
    42
    43
    44
    45

    A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S248, doi. 10.1016/j.clml.2019.07.153
    By:
    • Kalakonda, Nagesh;
    • Cavallo, Federica;
    • Follows, George;
    • Goy, Andre;
    • Vermaat, Joost S.P.;
    • Casasnovas, Olivier;
    • Lavee, Orly;
    • Maerevoet, Marie;
    • Zijlstra, Josée;
    • Bakhshi, Sameer;
    • Bouabdallah, Reda;
    • Choquet, Sylvain;
    • Gurion, Ronit;
    • Hill, Brian;
    • Jaeger, Ulrich;
    • Sancho, Juan-Manuel;
    • Schuster, Michael;
    • Thieblemont, Catherine;
    • De la Cruz, Fatima;
    • Egyed, Miklós
    Publication type:
    Article
    46
    47
    48
    49
    50